Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-05
DOI
10.1038/srep40258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
- (2016) Meiou Dai et al. Scientific Reports
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
- (2015) Xin Ye et al. NATURE
- p63 sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling
- (2015) Elisa Maria Memmi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metastatic Stem Cells: Sources, Niches, and Vital Pathways
- (2014) Thordur Oskarsson et al. Cell Stem Cell
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
- (2014) Antonina V. Kurtova et al. NATURE
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Breast cancer stem cells and epithelial mesenchymal plasticity – Implications for chemoresistance
- (2013) Cletus A. Pinto et al. CANCER LETTERS
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness
- (2013) Claudia Bocca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Emerging role of nanog in tumorigenesis and cancer stem cells
- (2013) Luis E. IV Santaliz-Ruiz et al. INTERNATIONAL JOURNAL OF CANCER
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties
- (2013) X Qian et al. ONCOGENE
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice
- (2012) Deepak Kanojia et al. PROTEOMICS
- TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer
- (2012) Alejandra Bruna et al. Nature Communications
- bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
- (2011) Pascal Jézéquel et al. BREAST CANCER RESEARCH AND TREATMENT
- TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype
- (2011) M. K. Asiedu et al. CANCER RESEARCH
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
- (2011) Christina Scheel et al. CELL
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- GOBO: Gene Expression-Based Outcome for Breast Cancer Online
- (2011) Markus Ringnér et al. PLoS One
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
- (2010) Salvatore Pece et al. CELL
- Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
- (2010) Sílvia Cufí et al. CELL CYCLE
- Role of COX-2 in Tumorospheres Derived from a Breast Cancer Cell Line
- (2010) Balraj Singh et al. JOURNAL OF SURGICAL RESEARCH
- Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
- (2010) Claudia Bocca et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
- (2009) C. Falandry et al. ANNALS OF ONCOLOGY
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration
- (2009) Wolfram Goessling et al. CELL
- Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
- (2009) M Petersen et al. ONCOGENE
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer
- (2008) Louis Wing-Cheong Chow et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
- (2008) Nicole C Allen et al. NATURE GENETICS
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
- (2008) Lilly Y.W. Bourguignon SEMINARS IN CANCER BIOLOGY
- Transforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors
- (2007) Annie Lacerte et al. CELLULAR SIGNALLING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now